Skip to main content
. 2015 Aug 15;8(8):14345–14351.

Table 1.

Characteristics of studies between tea consumption and thyroid cancer risk

Author (year) Country Study design Quality score Participants (case) Age range RR (95% CI) for highest vs. lowest category
D’Avanzo et al. (1995) Italy HCC 6 1016 (399) ≤ 75 1.13 (0.82-1.56)
Galanti et al. (1997) Norway PCC 7 312 (116) 18-75 1.16 (0.51-2.65)
Glattre et al. (1993) Norway HCC 7 552 (92) 20-59 1.33 (0.61-2.90)
Hallquist et al. (1993) Sweden PCC 6 540 (180) 20-70 0.93 (0.59-1.48)
Kolonel et al. (1990) United States PCC 7 632 (191) ≥18 0.75 (0.52-1.08)
Linos et al. (1989) Greece HCC 7 141 (70) Na 0.76 (0.43-1.33)
Mack et al. (2002) United States PCC 6 584 (292) 15-54 0.3 (0.1-1.0)
Michikawa et al. (2011) Japan Cohort 8 100507 (159) 40-69 Females: 0.91 (0.56-1.48)
Males: 0.71 (0.22-2.28)
Preston-Martin et al. (1987) United States PCC 7 220 (110) 15-40 0.51 (0.25-1.03)
Preston-Martin et al. (1993) China PCC 7 414 (207) 18-54 1.00 (0.25-4.03)
Riza et al. (2015) Greece HCC 6 1529 (1139) 42.8 Chamomile tea
0.25 (0.10-0.62)
Sage tea
0.34 (0.09-1.21)
Mountain tea
0.55 (0.21-1.41)

Abbreviations: Na: not available; PCC: population-based case-control study; HCC: hospital-based case-control study; BMI: body mass index.